Home-based Cardiac Rehabilitation in Heart Failure
This study is looking at a home-based cardiac rehabilitation program for people with heart failure. You would use a mobile app called Movn, which provides a 12-week exercise program, along with a Fitbit to track your activity and a blood pressure scale. The study aims to see if this program can help improve outcomes like mortality (death), hospitalizations, and quality of life over 6 months. To join, you need to be an adult (18 or older) who has been hospitalized for acute heart failure in the last year, can do telemedicine visits, and has a smartphone. The study is comparing the Movn program to a control group and is currently unclear about its recruitment status, with a plan to enroll 332 participants.
- Study design
- This is an interventional study that will randomize 332 participants with heart failure to either a 12-week home-based cardiac rehabilitation program using the Movn app or an attention control group.
- What's involved
- Participants will engage in a 12-week home-based exercise program using the Movn app, an accelerometer (Fitbit), and a blood pressure scale, and participate in telemedicine visits.
- Compensation
- Not stated in the trial record.
- Follow-up
- Outcomes will be measured over 6 months after starting the program.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Home-based Cardiac Rehabilitation in Heart Failure
At a glance
Conditions
NCT06349941
Where you'd take part
This study runs at 2 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Baylor Scott and White Health System
Dallas, Texasstudy coordinator listed
Recruiting
University of Texas Southwestern Medical Center
Dallas, Texasstudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Composite Hierarchical Endpoint6 months.
A composite outcome incorporating all-cause mortality, time to first heart failure hospitalization, total heart failure hospitalizations, and a 5-point difference in disease-specific quality of life score as assessed by the Kansas City Cardiomyopathy Questionnaire (KCCQ). The KCCQ ranges from 0-100, where 0 indicates worst quality of life and 100 indicates best quality of life.